copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Our Leaders | AbbVie Our board members work closely with AbbVie leaders to maintain our focus of putting patients first Robert A Michael Chairman of the Board and Chief Executive Officer AbbVie Inc North Chicago, Illinois Robert J Alpern, M D Ensign Professor of Medicine and Physiology, Professor of Internal Medicine and Cellular and Molecular Physiology, and
Robert A. Michael | AbbVie Rob Michael is the Chairman of the Board and Chief Executive Officer of AbbVie, a global biopharmaceutical company that employs approximately 55,000 people worldwide and has provided innovative medicines and products to more than 60 million people in over 175 countries
AbbVie Announces Appointment of Robert A. Michael as Chief Executive . . . NORTH CHICAGO, Ill , Feb 20, 2024 PRNewswire -- AbbVie (NYSE: ABBV) today announced that its board of directors has unanimously selected Robert A Michael, AbbVie's current president and chief operating officer, to succeed Richard A Gonzalez as the company's chief executive officer (CEO)
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of . . . NORTH CHICAGO, Ill , Feb 14, 2025 PRNewswire -- AbbVie (NYSE: ABBV) today announced that its board of directors has unanimously elected chief executive officer (CEO) Robert A Michael to assume the additional position of chairman, effective July 1, 2025
Robert A. Michael Assumes Role as AbbVie Chief Executive Officer NORTH CHICAGO, Ill , July 1, 2024 PRNewswire -- AbbVie (NYSE: ABBV) today announced that Robert A Michael has assumed the role of chief executive officer (CEO) and has joined AbbVie's Board of Directors, effective today
AbbVie Reports First-Quarter 2025 Financial Results AbbVie announced that its board of directors unanimously elected chief executive officer (CEO) Robert A Michael to assume the additional position of chairman of the board of directors, effective July 1, 2025
AbbVie Reports Second-Quarter 2025 Financial Results | AbbVie We also made meaningful pipeline progress with several regulatory approvals, encouraging clinical data and strategic investments in promising external innovation," said Robert A Michael, chairman and chief executive officer, AbbVie
Pharmaceutical Research Development | AbbVie AbbVie pharmaceuticals combines advanced science with expertise to make strides in drug and treatment discovery, making a remarkable impact on people's lives
Who We Are | AbbVie Never underestimate the power and dedication of ~55,000 employees around the world united in the same mission — to make a remarkable impact for our patients, improve our society and support our communities Robert A Michael Chairman of the Board and Chief Executive Officer